The goal of this clinical trial is to evaluate the effectiveness and safety of Antarctic Krill Oil (AKO) as a dietary supplement in managing pain associated with knee osteoarthritis (OA). The main questions it aims to answer are:
Does AKO reduce daily pain intensity in participants with moderate knee OA?
What adverse effects do participants experience when taking AKO?
Researchers will conduct a randomized, double-blind study comparing AKO to a placebo (identical appearance without active components) to assess:
* Changes in joint pain severity; Functional improvement in daily activities; Biochemical safety parameters,etc.